TNBC is a type of breast cancer that does not express hormone (estrogen or progesterone) receptors or human epidermal growth factor receptor 2 (HER2), which represent molecular targets for therapeutic agents [87,88,89]. This evidence concerns the gene ERBB2 and breast carcinoma.